|
Revenue Update on DaVita HealthCare(NYSE:DVA) - Money Flow Index |
 |
|
DaVita HealthCare(NYSE:DVA) announced the earnings results for Fiscal Year 2015 and Q2. The results came in during After-hours on Aug 4, 2015. Company reported revenue of $3.44B. The estimated revenue was of $3.37B. Earnings per share were $0.95. The reported EPS was above estimates by $0.01 or 1.06%. Analysts had estimated an EPS of $0.94.
DaVita healthCare Partners Inc. (NYSE:DVA) has dropped 0.45% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 0.11% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 1.6%. DaVita healthCare Partners Inc. (NYSE:DVA) has underperformed the index by 1.17% in the last 4 weeks. Investors should watch out for further signals and trade with caution. DaVita HealthCare Partners Inc. has dropped 4.09% during the last 3-month period . Year-to-Date the stock performance stands at 4.34%. The company shares have rallied 9.54% in the past 52 Weeks. On April 27, 2015 The shares registered one year high of $85.17 and one year low was seen on August 4, 2014 at $70.85. The 50-day moving average is $80.02 and the 200 day moving average is recorded at $79.7. S&P 500 has rallied 8.5% during the last 52-weeks. The company has received recommendation from many analysts. 5 analysts have rated the company as a strong buy. The shares have been rated as hold from 7 Wall Street Analysts. 1 analysts have suggested buy for the company. Underperform rating was given by 1 analyst.
DaVita healthCare Partners Inc. (NYSE:DVA) : On Friday heightened volatility was witnessed in DaVita healthCare Partners Inc. (NYSE:DVA) which led to swings in the share price. The shares opened for trading at $78.63 and hit $79.61 on the upside , eventually ending the session at $79.03, with a gain of 0.51% or 0.4 points. The heightened volatility saw the trading volume jump to 671,630 shares. The 52-week high of the share price is $85.17 and the company has a market cap of $16,987 million. The 52-week low of the share price is at $70.49 . Currently the company Insiders own 0.2% of DaVita HealthCare Partners Inc. Company shares. In the past six months, there is a change of -53.07% in the total insider ownership. Institutional Investors own 86.5% of Company shares. During last 3 month period, -0.03% of total institutional ownership has changed in the company shares. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director officer (Co-Chairman of the Board) of Davita Healthcare Partners Inc., Margolis Robert J had sold 31,400 shares worth of $2,619,074 in a transaction dated June 3, 2015. In this transaction, 31,400 shares were sold at $83.41 per share. DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysia’s Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.
|